Drug recall
Apheresis Red Blood Cells Deglycerolized, Leukocytes Reduced
FDA recall event 90350 · Class III · ImpactLife
Key facts
| Event ID | 90350 |
|---|---|
| Recall numbers | B-0410-2022, B-0411-2022, B-0412-2022 |
| Recalling firm | ImpactLife |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells Deglycerolized, Leukocytes Reduced, Red Blood Cells Deglycerolized, Leukocytes Reduced, Red Blood Cells Deglycerolized, Leukocytes Reduced, Irradiated |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Red Blood Cell products, labeled with incorrect volumes, were distributed. |
| Initiation date | May 4, 2022 |
| Report date | Jun 22, 2022 |
| Termination date | Jun 12, 2022 |
| City | Davenport |
| State | IA |
| Country | United States |
| FEI number | 1970356 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: